On February 2, 2021, HELIX IMMUNO-ONCOLOGY S.A. submitted the following documents to the Financial Document Repository for the fiscal year running from August 1, 2019 to July 31, 2020:

  1. Financial statement,
  2. Managing Board report on Company business activities,
  3. Auditor’s opinion / report on the audit of the annual financial statement
  4. Resolution on allocation of profit,
  5. Resolution on approval of the annual financial statement.